128 related articles for article (PubMed ID: 7342290)
1. Pharmacokinetics of vancomycin in anuria.
Cunha BA; Quintiliani R; Deglin JM; Izard MW; Nightingale CH
Rev Infect Dis; 1981; 3 suppl():S269-72. PubMed ID: 7342290
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of vancomycin when administered during high flux hemodialysis.
Foote EF; Dreitlein WB; Steward CA; Kapoian T; Walker JA; Sherman RA
Clin Nephrol; 1998 Jul; 50(1):51-5. PubMed ID: 9710347
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of vancomycin in normal subjects and in patients with reduced renal function.
Moellering RC; Krogstad DJ; Greenblatt DJ
Rev Infect Dis; 1981; 3 suppl():S230-5. PubMed ID: 7342286
[TBL] [Abstract][Full Text] [Related]
4. Vancomycin dosage requirements among pediatric intensive care unit patients with normal renal function.
Glover ML; Cole E; Wolfsdorf J
J Crit Care; 2000 Mar; 15(1):1-4. PubMed ID: 10757191
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of vancomycin in patients with severely impaired renal function.
Gonzalez-Martin G; Acuna V; Perez C; Labarca J; Guevara A; Tagle R
Int J Clin Pharmacol Ther; 1996 Feb; 34(2):71-5. PubMed ID: 8929749
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacologic clinical monitoring of serum vancomycin levels in pediatric patients].
Nandí-Lozano E; Ramírez-López E; Avila-Figueroa C
Rev Invest Clin; 2003; 55(3):276-80. PubMed ID: 14515672
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin pharmacokinetics in patients undergoing chronic intermittent peritoneal dialysis.
Glew RH; Pavuk RA; Shuster A; Alfred HJ
Int J Clin Pharmacol Ther Toxicol; 1982 Dec; 20(12):559-63. PubMed ID: 7152738
[TBL] [Abstract][Full Text] [Related]
8. Peritoneal clearance and total body elimination of vancomycin during chronic intermittent peritoneal dialysis.
Ayus JC; Eneas JF; Tong TG; Benowitz NL; Schoenfeld PY; Hadley KL; Becker CE; Humphreys MH
Clin Nephrol; 1979 Mar; 11(3):129-32. PubMed ID: 436339
[TBL] [Abstract][Full Text] [Related]
9. Adequacy of a vancomycin dosing regimen in patients receiving high-flux hemodialysis.
Ariano RE; Fine A; Sitar DS; Rexrode S; Zelenitsky SA
Am J Kidney Dis; 2005 Oct; 46(4):681-7. PubMed ID: 16183423
[TBL] [Abstract][Full Text] [Related]
10. Association of vancomycin serum concentrations with outcomes in patients with gram-positive bacteremia.
Zimmermann AE; Katona BG; Plaisance KI
Pharmacotherapy; 1995; 15(1):85-91. PubMed ID: 7739950
[TBL] [Abstract][Full Text] [Related]
11. Vancomycin serum levels and toxicity in chronic hemodialysis patients with Staphylococcus aureus bacteremia.
Masur H; Francioli P; Ruddy M; Murray HW
Clin Nephrol; 1983 Aug; 20(2):85-8. PubMed ID: 6616979
[TBL] [Abstract][Full Text] [Related]
12. Vancomycin population pharmacokinetics in neonates.
de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
[TBL] [Abstract][Full Text] [Related]
13. Clearance of vancomycin during high-efficiency hemodialysis.
Klansuwan N; Ratanajamit C; Kasiwong S; Wangsiripaisan A
J Med Assoc Thai; 2006 Jul; 89(7):986-91. PubMed ID: 16881431
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of imipenem and cilastatin during continuous venovenous hemodialysis in patients who are critically ill.
Hashimoto S; Honda M; Yamaguchi M; Sekimoto M; Tanaka Y
ASAIO J; 1997; 43(1):84-8. PubMed ID: 9116359
[TBL] [Abstract][Full Text] [Related]
15. Urea kinetics and dialysis treatment time predict vancomycin elimination during high-flux hemodialysis.
Schaedeli F; Uehlinger DE
Clin Pharmacol Ther; 1998 Jan; 63(1):26-38. PubMed ID: 9465839
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology and efficacy of vancomycin for staphylococcal infections in children.
Schaad UB; Nelson JD; McCracken GH
Rev Infect Dis; 1981; 3 suppl():S282-8. PubMed ID: 7342292
[TBL] [Abstract][Full Text] [Related]
17. Vancomycin pharmacokinetics in premature infants.
Gross JR; Kaplan SL; Kramer WG; Mason EO
Pediatr Pharmacol (New York); 1985; 5(1):17-22. PubMed ID: 3991250
[TBL] [Abstract][Full Text] [Related]
18. [Monitoring serum vancomycin concentrations in the treatment of Staphylococcus infections in children].
Mariani-Kurkdjian P; Nebbad H; Aujard Y; Bingen E
Arch Pediatr; 2008 Nov; 15(11):1625-9. PubMed ID: 18848438
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinectics of vancomycin and amikacin in the subeschar tissue fluid in patients with severe burn.
Yang RH; Rong XZ; Hua R; Zhang T
Burns; 2009 Feb; 35(1):75-9. PubMed ID: 18789586
[TBL] [Abstract][Full Text] [Related]
20. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia.
Jeffres MN; Isakow W; Doherty JA; Micek ST; Kollef MH
Clin Ther; 2007 Jun; 29(6):1107-15. PubMed ID: 17692725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
